Granahan Investment Management’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-100,874
Closed -$1.55M 240
2016
Q2
$1.55M Sell
100,874
-3,020
-3% -$47.9K 0.06% 195
2016
Q1
$1.62M Sell
103,894
-6,958
-6% -$90K 0.06% 200
2015
Q4
$1.36M Buy
110,852
+62,993
+132% +$834K 0.05% 220
2015
Q3
$613K Sell
47,859
-390
-0.8% -$4.92K 0.02% 249
2015
Q2
$584K Sell
48,249
-1,191
-2% -$16.3K 0.02% 233
2015
Q1
$654K Buy
49,440
+346
+0.7% +$4.67K 0.02% 229
2014
Q4
$698K Sell
49,094
-4,405
-8% -$76.3K 0.02% 207
2014
Q3
$1.46M Sell
53,499
-374
-0.7% -$11.4K 0.05% 201
2014
Q2
$2.17M Sell
53,873
-9,696
-15% -$359K 0.06% 194
2014
Q1
$2.45M Buy
63,569
+32,286
+103% +$1.14M 0.07% 195
2013
Q4
$1.06M Buy
31,283
+10,966
+54% +$291K 0.03% 204
2013
Q3
$387K Buy
20,317
+3,180
+19% +$55.6K 0.01% 213
2013
Q2
$265K Buy
+17,137
New +$362K 0.01% 226

Other funds holding FLNA

Granahan Investment Management's FLNA Position: Q3 2016 in Review

Granahan Investment Management sold out of Filana Therapeutics (FLNA) in Q3 2016, closing a stake of 100,874 shares — an estimated $1.55M sold.

Granahan Investment Management first reported a position in FLNA in Q2 2013 and held it in 13 quarters. The position peaked at $2.45M in Q1 2014. 48 funds tracked by Wall St. Rank hold FLNA as of Q3 2016.

  • Granahan Investment Management reported no remaining Filana Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Granahan Investment Management sold 100,874 Filana Therapeutics shares in Q3 2016, an estimated $1.55M.
  • Granahan Investment Management first reported a position in Filana Therapeutics in Q2 2013 and held it in 13 quarters.
  • Granahan Investment Management's Filana Therapeutics position peaked at $2.45M in Q1 2014.
  • 48 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2016.

Based on Granahan Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.